文献速递中枢神经肿瘤放疗胸部肿瘤放疗放疗物理与技术

立体定向放疗治疗非小细胞肺癌脑转移:两种不同放射组学平台间的预测不匹配

Brain metastases from NSCLC treated with stereotactic radiotherapy: prediction mismatch between two different radiomic platforms.
PubMed 文献 · Radiother Oncol · 2022-11-24

本研究分析148例非小细胞肺癌脑转移患者的276个转移灶,比较PyRadiomics与SOPHiA Radiomics两种平台提取的放射组学特征对局部控制、远处进展和总生存的预测能力。两种平台在可提取特征的质量和数量上存在差异,导致模型端到端性能、放射组学评分统计学显著性及联合模型中显著临床协变量出现不匹配。

要点

  • 两种放射组学平台提取特征的质量和数量存在差异。
  • 平台差异导致模型性能、放射组学评分显著性和显著临床协变量不匹配。
  • 该差异可能影响结论得出、文献间结果比较及放射组学临床转化。

核心结论

  • 从同一图像用两种不同平台提取放射组学特征可产生多种差异,可能对得出结论、比较文献结果及将放射组学转化为临床实践产生急性后果。

研究设计与样本

  • 研究使用放疗前钆增强轴位T1加权MRI扫描,经重采样、强度平移和直方图匹配后由PyRadiomics和SOPHiA Radiomics两种平台提取放射组学特征。
  • 采用LASSO Cox回归模型进行多变量分析,构建放射组学模型、临床模型和联合模型,使用局部控制、远处进展和总生存三个生存临床终点。
  • 统计分析重复50次并使用不同随机种子,以中位一致性指数作为模型性能指标。
  • 分析148例患者的276个转移灶。

主要发现

  • 两种平台的使用导致可提取特征的质量和数量均存在差异。
  • 该差异导致端到端性能、放射组学评分统计学显著性以及联合模型中显著临床协变量出现不匹配。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Radiomics enables the mining of quantitative features from medical images. The influence of the radiomic feature extraction software on the final performance of models is still a poorly understood topic. This study aimed to investigate the ability of radiomic features extracted by two different radiomic platforms to predict clinical outcomes in patients treated with radiosurgery for brain metastases from non-small cell lung cancer. We developed models integrating pre-treatment magnetic resonance imaging (MRI)-derived radiomic features and clinical data. MATERIALS AND METHODS: Pre-radiotherapy gadolinium enhanced axial T1-weighted MRI scans were used. MRI images were re-sampled, intensity-shifted, and histogram-matched before radiomic extraction by means of two different platforms (PyRadiomics and SOPHiA Radiomics). We adopted LASSO Cox regression models for multivariable analyses by creating radiomic, clinical, and combined models using three survival clinical endpoints (local control, distant progression, and overall survival). The statistical analysis was repeated 50 times with different random seeds and the median concordance index was used as performance metric of the models. RESULTS: We analysed 276 metastases from 148 patients. The use of the two platforms resulted in differences in both the quality and the number of extractable features. That led to mismatches in terms of end-to-end performance, statistical significance of radiomic scores, and clinical covariates found significant in combined models. CONCLUSION: This study shed new light on how extracting radiomic features from the same images using two different platforms could yield several discrepancies. That may lead to acute consequences on drawing conclusions, comparing results across the literature, and translating radiomics into clinical practice.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Carloni G, Garibaldi C, Marvaso G, et al. Brain metastases from NSCLC treated with stereotactic radiotherapy: prediction mismatch between two different radiomic platforms. Radiother Oncol. 2022. PMID: 36435336. doi:10.1016/j.radonc.2022.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。